Medpace (NASDAQ:MEDP – Get Free Report) had its target price hoisted by stock analysts at Robert W. Baird from $240.00 to $260.00 in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. Robert W. Baird’s price target indicates a potential upside of 1.36% from the company’s previous close. A number of other […]
Medpace (NASDAQ:MEDP – Get Free Report) issued its earnings results on Monday. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03, Briefing.com reports. Medpace had a net margin of 16.06% and a return on equity of 74.38%. The business had revenue of $460.90 million for the quarter, compared […]
Medpace (NASDAQ:MEDP – Get Free Report) announced its quarterly earnings results on Monday. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03, Briefing.com reports. Medpace had a net margin of 16.06% and a return on equity of 74.38%. The company had revenue of $460.90 million for […]
Medpace (NASDAQ:MEDP – Get Free Report) released its quarterly earnings data on Monday. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03, Briefing.com reports. The business had revenue of $460.90 million for the quarter, compared to analysts’ expectations of $433.75 million. Medpace had a return […]
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday following a better than expected earnings announcement. The company traded as high as $259.22 and last traded at $255.97, with a volume of 188363 shares trading hands. The stock had previously closed at $246.94. The company reported […]